专利信息

首页上页 1 2 3 4 5 6 7 8 下页尾页共 1259 条记录, 当前第3/126页。

专利标题：1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment

专利权人：H. Lundbeck A/s;

1-[2-(24-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT 5-HT

专利标题：New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine

专利权人：H. Lundbeck A/s;

专利标题：Manufacture of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine

专利权人：H. Lundbeck A/s;

The present invention relates to a process for the manufacture of 4-((1R3S)-6-Chloro-3-phenyl-indan-1-yl)-122-trimethyl-piperazine or a pharmaceutically acceptable salt thereof and a process for the manufacture of 1-((1R3S)-6-Chloro-3-phenyl-indan-1-yl)-33-dimethyl-piperazine or a pharmaceutically acceptable salt thereof.

专利标题：Method for the manufacturing of naltrexone.

专利权人：H. Lundbeck A/s;

The present invention relates to an improved process for producing naltrexone [17- (cyclopropylmethyl)-45Î±-epoxy-314-dihydroxy-morphinan-6-one] from noroxymorphone [45- Î±-epoxy-314-dihydroxy-morphinan-6-one] by alkylation with a cyclopropylmethyl halide.

专利标题：Phenyl-piperazine derivatives as serotonin reuptake inhibitors

专利权人：H. Lundbeck A/s;

专利标题：Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain

专利权人：H. Lundbeck A/s;

Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine and salts thereof are provided e.g. for the treatment of neuropathic pain.

专利标题：(3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl-thiomorpholin-4-yl) derivatives of 6,7-dialkoxy-quinazoline, 6,7-dialkoxyphtalazine and 6,7-dialkoxyisoquinoline as pde10a enzyme inhibitors

专利权人：H. Lundbeck A/s;

This invention is directed to compounds which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides a process for the preparation of the compounds of formula I. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a...

专利标题：Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsuflanyl)phenyl]piperazine

专利权人：H. Lundbeck A/s;

The invention provides new therapeutic uses of 1-[2-(24-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.

专利标题：Phenyl-piperazine derivatives as serotonin reuptake inhibitors

专利权人：H. Lundbeck A/s;

The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder including depression anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.

专利标题：Method for preparation of citalopram and intermediates used for them

专利权人：H. Lundbeck A/s;

当前查询条件: [专利权人] 包含 'H. Lundbeck A/s'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. AU2007260355B2	2013/8/15
专利标题：1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment 专利权人：H. Lundbeck A/s; 1-[2-(24-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT 5-HT

2. EP2470166B1	2013/8/14
专利标题：New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine 专利权人：H. Lundbeck A/s;

3. US8501947B2	2013/8/6
专利标题：Manufacture of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine 专利权人：H. Lundbeck A/s; The present invention relates to a process for the manufacture of 4-((1R3S)-6-Chloro-3-phenyl-indan-1-yl)-122-trimethyl-piperazine or a pharmaceutically acceptable salt thereof and a process for the manufacture of 1-((1R3S)-6-Chloro-3-phenyl-indan-1-yl)-33-dimethyl-piperazine or a pharmaceutically acceptable salt thereof.

4. MX2013005009A	2013/8/1	MX20130005009	2013/5/3
专利标题：Method for the manufacturing of naltrexone. 专利权人：H. Lundbeck A/s; The present invention relates to an improved process for producing naltrexone [17- (cyclopropylmethyl)-45Î±-epoxy-314-dihydroxy-morphinan-6-one] from noroxymorphone [45- Î±-epoxy-314-dihydroxy-morphinan-6-one] by alkylation with a cyclopropylmethyl halide.

5. HU228956B1	2013/7/29
专利标题：Phenyl-piperazine derivatives as serotonin reuptake inhibitors 专利权人：H. Lundbeck A/s;

6. US20130190352A1	2013/7/25
专利标题：Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain 专利权人：H. Lundbeck A/s; Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine and salts thereof are provided e.g. for the treatment of neuropathic pain.

7. US8492394B2	2013/7/23
专利标题：(3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl-thiomorpholin-4-yl) derivatives of 6,7-dialkoxy-quinazoline, 6,7-dialkoxyphtalazine and 6,7-dialkoxyisoquinoline as pde10a enzyme inhibitors 专利权人：H. Lundbeck A/s; This invention is directed to compounds which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides a process for the preparation of the compounds of formula I. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a...

8. US20130184291A1	2013/7/18
专利标题：Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsuflanyl)phenyl]piperazine 专利权人：H. Lundbeck A/s; The invention provides new therapeutic uses of 1-[2-(24-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.

9. US8476279B2	2013/7/2
专利标题：Phenyl-piperazine derivatives as serotonin reuptake inhibitors 专利权人：H. Lundbeck A/s; The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder including depression anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.

10. HU228744B1	2013/5/28
专利标题：Method for preparation of citalopram and intermediates used for them 专利权人：H. Lundbeck A/s;

下载范围

下载内容